More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression

被引:36
|
作者
Lyons, Taylor [1 ]
Carhart-Harris, Robin Lester [1 ]
机构
[1] Imperial Coll London, Dept Med, Psychedel Res Grp, London, England
来源
FRONTIERS IN PSYCHOLOGY | 2018年 / 9卷
关键词
treatment-resistant depression; psilocybin; cognitive bias; pessimism; forecasting; LYSERGIC-ACID DIETHYLAMIDE; DEFAULT-MODE NETWORK; MYSTICAL-TYPE EXPERIENCES; 5-HT2A RECEPTOR-BINDING; DYSFUNCTIONAL ATTITUDES; SPIRITUAL SIGNIFICANCE; UNREALISTIC OPTIMISM; POSITIVE ILLUSIONS; THREATENING CANCER; HEALTHY-SUBJECTS;
D O I
10.3389/fpsyg.2018.01721
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Evidence suggests that classical psychedelics can promote enduring changes in personality, attitudes and optimism, as well as improvements in mental health outcomes. Aim: To investigate the effects of a composite intervention, involving psilocybin, on pessimism biases in patients with treatment-resistant depression (TRD). Methods: Patients with TRD (n = 15) and matched, untreated non-depressed controls (n = 15) performed the Prediction Of Future Life Events (POFLE) task. The POFLE task requires participants to predict the likelihood of certain life events occurring within a 30day period, after which the actual rate of event occurrence is reported; this gives an index of potential pessimism versus optimism bias. Psilocybin was administered in two oral dosing sessions (10 and 25 mg) one week apart. Main outcome measures were collected at baseline and one week after the second dosing session. Results: Patients showed a significant pessimism bias at baseline [t(14) = 3.260, p = 0.006; 95% CI (-0.16, -0.03), g = 1.1] which was related to the severity of their depressive symptoms (r(s) = 0.55, p = 0.017). One week after psilocybin treatment, this bias was significantly decreased [t(14) = 2.714, p = 0.017; 95% CI (-0.21, -0.02), g = 0.7] and depressive symptoms were greatly improved [t(14) = 7.900, p < 0.001; 95% CI (16.17, 28.23), g = 1.9]; moreover, the magnitude of change in both variables was significantly correlated (r = -0.57, p = 0.014). Importantly, post treatment, patients became significantly more accurate at predicting the occurrence of future life events [t(14) = 1.857, p = 0.042; 95% CI (-0.01, 0.12), g = 0.6] whereas no such change was observed in the control subjects. Conclusion: These findings suggest that psilocybin with psychological support might correct pessimism biases in TRD, enabling a more positive and accurate outlook.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Treatment-resistant depression in later life
    El Bayoumi, Heba
    Ismail, Zahinoor
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2015, 40 (06): : E34 - E35
  • [22] Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
    Mertens, Lea J.
    Wall, Matthew B.
    Roseman, Leor
    Demetriou, Lysia
    Nutt, David J.
    Carhart-Harris, Robin L.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (02) : 167 - 180
  • [23] Treatment-resistant depression: a challenge for future research
    Kasper, Siegfried
    ACTA NEUROPSYCHIATRICA, 2014, 26 (03): : 131 - 133
  • [24] Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
    J. B. Stroud
    T. P. Freeman
    R. Leech
    C. Hindocha
    W. Lawn
    D.J. Nutt
    H.V Curran
    R. L. Carhart-Harris
    Psychopharmacology, 2018, 235 : 459 - 466
  • [25] Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
    Stroud, J. B.
    Freeman, T. P.
    Leech, R.
    Hindocha, C.
    Lawn, W.
    Nutt, D. J.
    Curran, H. V.
    Carhart-Harris, R. L.
    PSYCHOPHARMACOLOGY, 2018, 235 (02) : 459 - 466
  • [26] Ketamine in Late Life Treatment-Resistant Depression
    Heard, Erika
    Sohail, Yousuf
    Nagar, Anusuiya
    Glass, Oliver M.
    Hermida, Adriana P.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (03): : S66 - S66
  • [27] Single-Dose psilocybin for veterans with severe treatment-resistant depression: Effects on anxiety, functioning, and quality of life
    Ellis, Sara
    Kelly, Carlton M.
    Bostian, Catherine
    Donnelly, Anna
    Fischer, Eileen
    Feng, Wendy
    Schwartz, Garrett
    Eisen, Katherine
    Lean, Melanie
    Conlan, Betsy
    Lyu, Jihun
    Ostacher, Michael
    Aaronson, Scott
    Suppes, Trisha
    BIPOLAR DISORDERS, 2024, 26 : 96 - 96
  • [28] TREATMENT-RESISTANT DEPRESSION: RECENT DEVELOPMENTS AND FUTURE DIRECTIONS
    Mathew, Sanjay J.
    DEPRESSION AND ANXIETY, 2008, 25 (12) : 989 - 992
  • [29] Psilocybin Assisted Therapy for Treatment-Resistant Depression: A Phase II, Randomized, Feasibility Study
    Rosenblat, Joshua
    McIntyre, Roger
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 203 - 203
  • [30] Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis
    Fang, Qiwen
    Chan, Vivien Kin Yi
    Chan, Sandra Sau Man
    Jiao, Yuanshi
    Wang, Jiaqi
    Li, Xue
    PSYCHIATRY RESEARCH, 2024, 337